Options Grant. Pursuant to the Holding Company’s 2002 Stock Option Plan (the “Plan”), the Holding Company hereby grants to Executive five (5) separate nonqualified stock options (each an “Option” and individually referred to as the “First Option,” the “Second Option,” the “Third Option,” the “Fourth Option,” and the “Fifth Option”), to purchase 2,197.80 (the “Base Amount”) shares of Common (the “Option Shares”) (which number may be adjusted as provided in the Plan), at a price per share of $1.00 (the “Exercise Price”). The stock options so granted shall not be intended to be “incentive stock options” within the meaning of Section 422 of the Internal Revenue Code.
Options Grant. The Company hereby grants to Executive options to purchase (x) 33,333 shares of Class L Common ("Class L Option Shares") at an exercise price of $13.50 per share (the "Class L Exercise Price") and (y) 300,000 shares of Class A Common ("Class A Option Shares"; and together with the Class L Option Shares, the "Option Shares") at an exercise price of $.1667 per share (the "Class A Exercise Price"). The Class L Exercise Price and the Class A Exercise Price are collectively referred to herein as "Option Prices" and individually as an "Option Price". The Options will be immediately exercisable and, subject to earlier expiration as provided in subsection 1(b) below, will expire on the Expiration Date. The Options are not intended to be "incentive stock options" within the meaning of Section 422A of the Internal Revenue Code of 1986, as amended.
Options Grant. Parent Company grants to Executive an option to purchase 120,000 shares of the common stock of Parent Company, subject to the provisions set forth in this subsection (d) if, during the term of this Agreement, Executive increases Company's earnings and revenue growth as set forth herein. The option shall vest as follows:
Options Grant. The Company has awarded key management of the Company 300,000 options, pursuant to the Company's Stock Option Plan, exercisable at a price of $0.50 per common share, vesting in December 2020. About Nextleaf Solutions Nextleaf Solutions Ltd. ("OILS") is developing disruptive intellectual property for industrial-scale extraction, purification and formulation of cannabinoids. OILS owns a portfolio of eight (8) issued and over 35 pending patents pertaining to the production of high-purity, cannabinoid rich distillate, the key ingredient used in the manufacturing of standardized THC and CBD infused products. Once cannabis concentrates and edibles become legal across Canada, OILS plans to commercialize its intellectual property portfolio through IP licensing, B2B processing services, and the supply of THC and CBD oils and concentrates to qualified Canadian and international partners. Nextleaf Solutions trades as OILS on the Canadian Securities Exchange (CSE: OILS), OILFF on the OTCQB Market in the United States (OTCQB: OILFF) and L0MA on the Frankfurt Stock Exchange (FSE: L0MA). Contact: Xxxx Xxxxx, Investor Relations 000-000-0000 (ext. 201) xxxxxxxxx@xxxxxxxxxxxxxxxxx.xxx For more information visit xxx.xxxxxxxxxxxxxxxxx.xxx or follow OILS across social media platforms: Twitter, LinkedIn, Facebook , Instagram and YouTube. CAUTIONARY STATEMENT: The securities described herein, if any, have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws, and may not be offered or sold within the United States or to, or for the benefit of, U.S. persons (as defined in Regulation S under the U.S. Securities Act) except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to exemptions therefrom. This release does not constitute an offer to sell or a solicitation of an offer to buy of any of Nextleaf Solutions securities in the United States. This news release may contain "forward-looking information" as defined in applicable Canadian securities legislation. All statements other than statements of historical fact included in this release, including, without limitation, future operating margins, future production and processing, processing results, and future plans and objectives of Nextleaf Solutions, constitute forward looking information that involve various risks and uncertainties. Forward-looking informa...
Options Grant. Executive shall receive options in the amounts and on the terms set forth in Schedule A hereto, subject to approval by the Board of Directors of the Company or the appropriate Committee thereof.
Options Grant. This Agreement shall evidence the grant and award to Optionee under the NQSO Plan of Options to purchase 500,000 shares of the voting Common Stock of the Company. The Option Price is $0.38 per share which was the closing price of the Common Stock on September 25, 2018. Unless otherwise agreed to in the attached Employment Agreement or in writing under a separate written agreement executed by the Parties, the Options are exercisable during a period of ten (10) years from the Effective Date and shall vest 33.33% annually, commencing one (1) year from the Effective Date. The Options are exercisable, in whole or in part or from time to time during the aforesaid term. Additionally, any option rights acquired by Optionee from third parties shall be in addition to the aforementioned Options Grants (“Assigned Options”). The Assigned Options: (a) shall be governed by a separate assignment agreement between Optionee and the assignor; (b) that are vested at the time of assignment shall likewise be vested in favor of Optionee; (c) that are not vested at the time of assignment shall shall be subject to the vesting schedule under this section; and (d) notwithstanding the exercise dates and terms applicable to assignor, the Optionee (as assignee of the options) shall exercise any such assigned options in accordance with this section. AINOS INC Employment Agreement – Effective August 1 2021 LAXXXXXX XXX
Options Grant. Xxxxx shall receive "non-qualified" options to purchase all, or any portion of, One Hundred Thousand (100,000) shares of Derma common stock at a
Options Grant. The Company shall recommend to the Board that the Executive be granted options to purchase 900,000 shares of Stock (the “Options”) as soon as reasonably practicable following the execution of this Agreement. The Options shall have an exercise price equal to the Fair Market Value of the shares of Stock on the date of grant and shall consist of the following: (i) 600,000 shares subject to the Options shall have time-based vesting terms (the “Time Based Options”) with one-third of such shares vesting on each yearly anniversary of the date of grant, and (ii) 300,000 shares subject to the Options shall have performance-based vesting terms (the “Performance-Based Options”) with (a) one-third of such shares vesting when the trading price target of $3.50 per share is met in accordance with the applicable option agreement, (b) an additional one-third of such shares vesting when the trading price target of $5.00 per share is met in accordance with the applicable option agreement, and (c) the remaining one-third of such shares vesting when the trading price target of $6.50 per share is met in accordance with the applicable option agreement. The forms of such option agreements for the Time-Based Options and the Performance-Based Options are attached hereto as Exhibit A hereto.
Options Grant. The Company shall, upon the earlier of the Effective or the date when the Company’s 2020 Share Incentive Plan (the “Plan”) is amended to increase the number of shares of common stock available for grant,, grant Executive up to 275,000 (Two hundred seventy five thousand) options (the “Options”) to purchase common stock of the Company with an exercise price of $.001 per share. The Options shall vest equally over five years at the rate of one-fifth (1/5th) beginning on the first anniversary date of the Effective Date. No Options shall vest after the termination of Executive’s employment and any unvested Options shall be forfeited upon the termination of Executive’s employment. All terms of the Options granted under this Agreement shall be governed by the Plan. Insofar as the Plan and this Agreement conflict, the terms of the Plan shall govern.
Options Grant. The Company hereby grants to Executive options to ------------- purchase (x) 229,922 shares of Class A Common ("Class A Option Shares") at an --------------------- exercise price of $0.044 per share (the "Class A Exercise Price") and (y) 25,547 ---------------------- shares of Class L Common ("Class L Option Shares" and together with the Class A --------------------- Option Shares, the "Option Shares") at an exercise price of $3.60 per share (the ------------- "Class L Exercise Price"). The Class A Exercise Price and the Class L Exercise ---------------------- Price are collectively referred to herein as "Option Prices" and individually -------------- as "Option Price". The option to purchase Class A Option Shares may be ------------ exercised independently of the option to purchase Class L Option Shares, and likewise the option to purchase Class L Option Shares may be exercised independently of the option to exercise Class A Option Shares. The Options will be immediately exercisable and, subject to earlier expiration as provided in subsection 1(b) below, will expire on the Expiration Date. The Options are not intended to be "incentive stock options" within the meaning of Section 422A of the Code.
